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Pompe disease is a lysosomal storage disorder associated with systemic deﬁciency of acid
α-glucosidase (GAA). Respiratory-related problems in Pompe disease include hypoventila-
tion and upper airway dysfunction. Although these problems have generally been attributed
to muscular pathology, recent work has highlighted the potential role of central nervous
system (CNS) neuropathology in Pompe motor deﬁciencies. We used a murine model of
Pompe disease to test the hypothesis that systemic GAA deﬁciency is associated with
hypoglossal (XII) motoneuron pathology and altered XII motor output during breathing.
Brainstem tissue was harvested from adult Gaa−/ − mice and the periodic acid Schiff
method was used to examine neuronal glycogen accumulation. Semi-thin (2μm) plas-
tic sections showed widespread medullary neuropathology with extensive cytoplasmic
glycogen accumulation in XII motoneuron soma. We next recorded efferent XII bursting
in anesthetized and ventilated Gaa−/ − and B6/129 mice both before and after bilateral
vagotomy. The coefﬁcient of variation of respiratory cycle duration was greater in Gaa−/ −
compared to B6/129 mice (p< 0.01). Vagotomy caused a robust increase in XII inspiratory
burst amplitude in B6/129 mice (239± 44% baseline; p< 0.01) but had little impact on
burst amplitude in Gaa−/ − mice (130± 23% baseline; p> 0.05). We conclude that CNS
GAA deﬁciency results in substantial glycogen accumulation in XII motoneuron cell bodies
and altered XII motor output. Therapeutic strategies targeting the CNS may be required to
fully correct respiratory-related deﬁcits in Pompe disease.
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INTRODUCTION
Glycogen storage disease type II or Pompe disease is caused by a
systemic lack of functional acid α-glucosidase (GAA). The preva-
lence of Pompe disease is approximately 1 per 40,000 births
(Ausems et al., 1999;Hirschhorn andReuser,2001),and this condi-
tion is associated with extensive glycogen accumulation in skeletal
muscle, visceral organs, and the central nervous system (CNS;
Raben et al., 2002; Sidman et al., 2008; DeRuisseau et al., 2009).
Clinically, Pompe syndromes can be classiﬁed as early (infan-
tile) and late-onset (juvenile/adult). However, these classiﬁcations
represent a disease continuum related to the extent of enzyme deﬁ-
ciency (Byrne et al., 2011a). Infantile Pompe disease is associated
with complete or near complete GAA deﬁciency but late-onset
patients maintain some residual GAA activity (Hirschhorn and
Reuser, 2001; Raben et al., 2002). Respiratory insufﬁciency is a
common symptom in both infantile and late-onset Pompe dis-
ease (Mellies et al., 2005; Pellegrini et al., 2005; Burghaus et al.,
2006; Mellies and Lofaso, 2009). Pompe infants typically present
at 4–6months of age with “respiratory difﬁculty” being noted as
the ﬁrst symptom in 25% of cases (van den Hout et al., 2003).
Respiratory failure is listed as the cause of death in 19% of
documented cases (Byrne et al., 2011a). Late-onset patients usu-
ally show progressive respiratory weakness and eventual failure.
Thus, approximately 75% of children and adolescents with Pompe
disease eventually require mechanical ventilation (Haley et al.,
2003; Marsden, 2005). In adult patients, vital capacity and peak
inspiratory pressures are reduced, and arterial hypoxemia, and
hypercapnia are common (Mellies et al., 2005). Approximately
33% of adult Pompe patients will eventually require mechani-
cal ventilatory support and both pneumonia and bronchitis are
prevalent (Hagemans et al., 2005).
Although motor problems in Pompe disease have historically
been attributed to muscular pathology (Raben et al., 2002), glyco-
gen accumulation in the CNS has been documented in Pompe
tissues (Mancall et al., 1965; Gambetti et al., 1971; Martin et al.,
1973; Martini et al., 2001; Teng et al., 2004; DeRuisseau et al.,
2009), and in various Pompe animal models (Matsui et al., 1983;
Sidman et al., 2008; DeRuisseau et al., 2009). Clinical case reports
also highlight the involvement of the CNS in motor (Clement
and Godman, 1950; Zellweger et al., 1955; Hogan et al., 1969;
Willemsen et al., 1998; Teng et al., 2004) and possibly cognitive
deﬁciencies (Rohrbach et al., 2010) in Pompe disease. We recently
www.frontiersin.org June 2011 | Volume 2 | Article 31 | 1
Lee et al. Hypoglossal motoneurons in Gaa−/ − mice
reported spinal (phrenic) respiratory motoneuron pathology and
reduced minute ventilation in the adult Gaa−/− mouse model of
Pompe disease (DeRuisseau et al., 2009; Mah et al., 2010). Similar
neuropathologywas noted in putative phrenicmotoneurons in the
cervical ventral horn of spinal tissue from aPompe infant obtained
at autopsy (DeRuisseau et al., 2009). We therefore have proposed
that phrenic motoneuron pathology may contribute to respira-
tory insufﬁciency in Pompe disease (DeRuisseau et al., 2009).
However, breathing also involves activation of pharyngeal and
laryngeal muscles controlled by supraspinal motoneurons (Feld-
man and Del Negro, 2006). Hypoglossal (XII) motoneurons are
of particular importance to upper airway patency as these cells
regulate the shape, stiffness, and position of the tongue (Rem-
mers et al., 1978; Fregosi and Fuller, 1997; Bailey and Fregosi,
2004; Gestreau et al., 2005). In particular, contraction of the
extrinsic tongue muscles (e.g., the genioglossus muscle) can dilate
and/or stiffen the pharyngeal lumen, thereby minimizing airway
narrowing, and/or collapse in the face of negative inspiratory pres-
sures (Fuller et al., 1999). Although there is clinical evidence of
XII motor dysfunction in Pompe disease (Margolis et al., 1994;
Muller et al., 2009; Jones et al., 2010; Byrne et al., 2011a), to our
knowledge there have been no detailed studies of respiratory-
related XII motor control in Pompe patients or relevant animal
models. Sidman et al. (2008) recently described brainstem neu-
ropathology in the 6neo/6neo mouse Pompe model but did not
comment on the appearance of XII motoneurons. Accordingly,
we used Gaa−/− mice (Raben et al., 1998) to test the hypothesis
that systemic GAA deﬁciency is associated with XII motoneu-
ron pathology and altered efferent XII motor output during
breathing.
MATERIALS AND METHODS
ANIMALS
All experimental procedures were approved by the Institutional
Animal Care and Use Committee at the University of Florida.
B6/129 mice (age 11± 1month) and Gaa−/− mice of similar
age (12± 1month, p = 0.54) were used in the majority of this
work. Histological studies were conducted using N = 7 B6/129
and N = 6 Gaa−/− mice. Neurophysiological studies (e.g., nerve
recordings; see below) were completed in N = 10 B6/129 and
N = 15 Gaa−/− mice. A few additional histological studies were
conducted in 129mice to test cholera toxinβ-subunit (CT-β) label-
ing of the XII nucleus (N = 4, age 4–5weeks). The Gaa−/− mice
were previously described (Raben et al., 1998; DeRuisseau et al.,
2009), and originally obtained from Taconic, Inc. Prior to initiat-
ing these experiments, a subset of Gaa−/− mice were genotyped
using standard PCR methods to conﬁrm the absence of the GAA
gene (Raben et al., 1998; Mah et al., 2007). Brieﬂy, DNA was iso-
lated from tail snips and ampliﬁed using primers to exons ﬁve and
seven of the mouse GAA gene. A 692-bp product indicated the
wildtype allele and a 2-kb product conﬁrmed the insertion of a
neo cassette and was detected in Gaa−/− mice.
BRAINSTEM HISTOLOGY
Brainstem tissues were embedded in parafﬁn or in epoxy resin
(Lane et al., 2008). Mice were anesthetized with sodium pen-
tobarbital (100mg/kg, i.p.) and euthanized via systemic perfu-
sion. The perfusate was either 4% paraformaldehyde (prior to
parafﬁn tissue embedding) or 4% paraformaldehyde and 3.5%
glutaraldehyde (prior to plastic embedding). Parafﬁn embedding
of the tissue was done with standard procedures (Mah et al., 2007).
The plastic embedding methods have also been described (Lane
et al., 2007, 2008). Visual conﬁrmation of glycogen accumulation
was accomplished using the periodic acid Schiff (PAS) staining
method (Guth and Watson, 1968; Sidman et al., 2008; DeRuisseau
et al., 2009). Brieﬂy, tissues were incubated in 0.5% periodic acid
(Richard-Allan Scientiﬁc Inc., Kalamazoo, MI, USA) for 10min at
60˚C, rinsed with tap water and then stained with Schiff ’s reagent
(Richard-Allan Scientiﬁc Inc.) for 5min, and then rinsed again in
tap water. Plastic sections were then counterstained with toluidine
blue (Lane et al., 2008) for 15–30 s. The XII motor nucleus was
retrogradely labeled by injecting CT-β (0.1% in 0.1M PBS) into
the base of the tongue. Mice were anesthetized as described above
and the tongue was gently protruded using ﬁne forceps. One or
two injections (2–5 μl/site) were then made lateral to the lingual
frenulum. Animals were sacriﬁced 60 h post-injection and CT-β
labeled neurons were detected as previously described (Lane et al.,
2008).
XII NERVE RECORDINGS
These procedures were adapted from our recent report (DeRuis-
seau et al., 2009). Mice were anesthetized with urethane (1.0–
1.6mg/kg, i.p., Sigma, St. Louis, MO, USA) and placed in a supine
position. Body temperature was maintained at 37–38˚C using a
servo-controlled heating pad (model TC-1000, CWE, Ardmore,
PA, USA). The trachea was cannulated below the larynx to enable
mechanical ventilation (model SAR-830/AP; CWE) with a hyper-
oxic gas mixture (FIO2 = 0.50–0.60). The ventilator frequency
was maintained at 150 cycles/min with inspiratory duration set at
0.33 s. The resulting minute ventilation values ranged from 15 to
18ml/min/10 g body weight, and were based on prior descriptions
of respiratory volumes in unanesthetized Gaa−/− and B6/129
mice (Mah et al., 2007; DeRuisseau et al., 2009). Pulse oxime-
try (MouseOx, STARR Life Science Corp., Oakmont, PA, USA)
was used to measure the saturation of hemoglobin (SaO2,%) in
ﬁve of nine B6/129 mice and 5 of 11 Gaa−/− mice. In each case
the measured SaO2 exceeded 96% throughout the experiment.
After initiating mechanical ventilation, mice were paralyzed by
i.p. administration of pancuronium bromide (2.5mg/kg, Hos-
pira, Inc., Lake Forest, IL, USA). The phrenic and XII nerves were
isolated unilaterally and the distal ends of each nerve were cut
prior to initiating the recordings. Nerve activity was recorded
using monopolar silver wire electrodes following ampliﬁcation
(1000×, Model 1700, A-M Systems, Carlsborg, WA, USA) and
band-pass ﬁltering (0.3–10KHz). The raw neurograms were inte-
grated using a 100-ms time constant (model MA-1000; CWE).
Data were digitized (CED Power 1401) and recorded on a PC
using Spike2 software (Cambridge Electronic Design Limited,
Cambridge, England).
DATA ANALYSIS
Inspiratory time (T I), expiratory time (TE), and the overall respi-
ratory cycle duration (TTOT) were calculated from the integrated
phrenic neurogramas previously described (Lee et al., 2009). Effer-
ent burst amplitude was assessed by measuring the peak height of
integrated neurogramsduring eachneural breath (Lee et al., 2009).
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Burst amplitude was ﬁrst quantiﬁed using the “raw” output of the
ampliﬁer (arbitrary units, a.u.) and was also normalized to the
baseline condition (% baseline). The “area under the curve” for
each integrated neural breath was also calculated and expressed as
a.u.∗s or%baseline.However,all burst amplitude resultswere both
qualitatively and quantitatively similar when analyzed as “peak
height” or “area under the curve,” and accordingly we present only
the peak height. The pre-inspiratory (Pre-I) component of the
XII burst was calculated as previously described (Lee and Fuller,
2010a).Data fromeach individualmousewere averagedover 3min
periods, and the overallmean responseswere calculated from these
values. The variability of the respiratory pattern was quantiﬁed
by calculating the coefﬁcient of variation [i.e., 100× (standard
deviation/mean)] for all parameters. When all mice had mea-
surements during both vagotomized and vagal-intact conditions
(e.g., XII amplitude, a.u.), statistical comparisons between B6/129
and Gaa−/− mice (i.e., “strain effects”) were made using two way
repeated measures (RM) analysis of variance (ANOVA). If data
werenot obtained inboth conditions in allmice,a twowayANOVA
was used to compare the strains. In cases in which only a single
data point was compared (e.g., XII amplitude, % vagal-intact),
a one-tailed t -test was used to compare the groups. All data are
expressed as the mean ± standard error. Data were considered to
be statistically different when the p-value was<0.05.
RESULTS
BRAINSTEM HISTOLOGY
The XII nucleus was observed immediately caudal and lateral to
the central canal in the medulla (Figures 1 and 2) as previously
reported in mice (Millecamps et al., 2001). Our initial histo-
chemistry experiments were performed using parafﬁn-embedded
tissues, and PAS staining produced signiﬁcant reaction product in
neuronal cell bodies within the XII nucleus of Gaa−/− but not
B6/129 mice (Figures 1A–D). The location of the XII nucleus was
also conﬁrmedusingCT-β tongue injections (Figures 1E,F). Semi-
thin (2μm) plastic sections were also evaluated from Gaa−/−
mice, and these revealed widespread medullary neuropathology
(Figure 2). Deposits of PAS positivematerial were readily observed
in XII motoneuron cytoplasm (Figures 2A–C) and nuclei were
free of PAS positive material (Figure 2C). A gradient of cyto-
plasmic inclusions could be observed across cells with some neu-
rons appearing to be virtually ﬁlled with glycogen droplets (e.g.,
Figure 2B). PAS positive inclusions were also noted in ependymal
cells near the central canal (Figure 2A) as well as in astrocytic
cells (Figure 2D). However, there was no indication of overt
axonal pathology (Figures 2D,E). Although not a primary focus
of this work, we also noted robust PAS staining in neuronal cyto-
plasm within the nucleus ambiguous (Figure 2F). The nucleus
ambiguous contains pharyngeal and laryngeal motoneurons, and
accordingly neuropathology in this region could contribute to
upper airway dysfunction.
PATTERN OF RESPIRATORY OUTPUT
Representative examples of XII neurograms recorded in anes-
thetized mice are provided in Figure 3. The “double bursting”
pattern illustrated in Figure 3 for the Gaa−/−mouse occurred in
33% (5/15) of Gaa−/− mice and 10% (1/10) B6/129 mice.
FIGURE 1 | Medullary sections showing XII motor neurons. (A–D) Show
parafﬁn-embedded tissues cut at 10μm and stained with the PAS method.
Positive PAS staining was not observed within neuronal cell bodies of
B6/129 mice (A,B). In contrast, XII motoneurons and cells in the
surrounding areas showed robust PAS staining in Gaa−/ − mice (C,D).
(B and D) Are higher magniﬁcation images of the areas indicated in
(A and C); arrows indicate individual XII motoneurons. (E) Shows an
example of CT-β labeling of the XII nuclei following tongue injection. (F)
Shows a parafﬁn-embedded medullary section from a Gaa−/ − mouse in
which XII motoneurons were retrogradely labeled with CT-β. This section
was also stained with the PAS method, and labeled XII motoneurons
(arrows) show PAS staining consistent with what was presented in (C,D).
cc, Central canal; scale bars: (A,C,E): 100μm; (B,D,F): 50μm.
In the vagal-intact condition, inspiratory burst frequency was
similar between groups (B6/129: 123± 11 bursts/min; Gaa−/−:
126± 8 bursts/min). Following cervical vagotomy, inspiratory
burst frequency was signiﬁcantly reduced in both groups of mice
(p< 0.05, Table 1). While overall burst frequency was not dif-
ferent, the respiratory cycle showed greater variability in Gaa−/−
compared to B6/129 mice (Figure 4). On average, the coefﬁcient
of variation of T I, TE, and TTOT were all increased in Gaa−/−
mice (two way ANOVA, strain effect, all p< 0.05; Figure 5).
The inspiratory burst onset recorded in the phrenic and XII
nerves was similar in the vagal-intact condition. In other words,
Pre-I XII bursting (Lee et al., 2007b) could not be discerned in
either experimental group with vagus nerves intact. However, fol-
lowing vagotomy clear Pre-I XII activity was observed in B6/129
but not Gaa−/− mice (Figure 6). The ﬁnding in B6/129 mice
is consistent with our prior reports showing that Pre-I bursting
is much more robust following vagotomy (Lee et al., 2007a,b).
Pre-I bursting probably plays a role in stabilizing the upper air-
ways before inspiration, and accordingly these data may indicate
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FIGURE 2 | Plastic-embedded semi-thin medullary sections (2μm)
show neuronal glycogen accumulation in Gaa−/− mice. Sections were
stained with PAS and toluidine blue. (A) Provides a low power view
including both hypoglossal nuclei; (B) is a higher resolution image of the
area indicated by the box in (A). These images demonstrate that PAS
staining within the XII nuclei is restricted to neuronal cell bodies. Ependymal
cells around the central canal (CC) also showed robust PAS staining (A). (C)
Shows a high magniﬁcation of PAS staining within a XII motoneuron – note
the extensive accumulation of glycogen droplets in the cytoplasm with no
positive nuclear staining. The image in (D) is from the ventral medulla near
the pyramidal decussation. PAS positive neuroglial cells were noted
(indicated by the arrows) but axons appear to be healthy with no evidence
of glycogen accumulation. Similarly, glycogen accumulation was not
observed in medullary axons including cranial nerve ﬁbers (E). Finally, (F)
depicts the extensive neuronal glycogen accumulation within the nucleus
ambiguous in the rostral medulla. Although not the primary focus of this
work, this image is included to illustrate that neuropathology in upper
airway motor systems in Gaa−/ − mice is not limited to the XII motor
nucleus. Scale bars: (A): 100μm; (B,D–F): 50μm; (C): 20μm.
that Gaa−/− mice have reduced airway patency during conditions
associated with increased respiratory drive.
AMPLITUDE OF XII AND PHRENIC BURSTING
Assessment of inspiratory XII burst amplitude (a.u.) revealed an
interaction (p = 0.045) between strain and condition with differ-
ences between B6/129 and Gaa−/− mice becoming evident after
vagotomy. During the baseline vagal-intact condition, XII burst
amplitude (a.u.) tended to be greater in B6/129 (0.18± 0.04)
than Gaa−/− mice (0.11± 0.04), but this difference was not sta-
tistically signiﬁcant (p> 0.05; Figure 7). Following vagotomy,
however, XII burst amplitude (a.u.) was considerably greater in
B6/129 (0.40± 0.13) than Gaa−/− mice (0.12± 0.03; p = 0.007;
Figure 7). The normalized XII burst amplitudes conﬁrmed this
FIGURE 3 | Examples of efferent XII nerve activity in B6/129 and
Gaa−/− mice under vagal-intact and vagotomized conditions. Both
“raw” and integrated (
∫
) neurograms are shown. In the vagal-intact
condition, the amplitude of the XII signal is similar between the two mice,
but the Gaa−/ − mouse shows more variability in the timing of the
respiratory cycle. Following bilateral cervical vagotomy there is a robust
increase in XII burst amplitude in the B6/129 mouse whereas the Gaa−/ −
mouse shows little change.
Table 1 | Respiratory cycle duration and frequency in B6/129 and
Gaa−/− mice.
T I (s) T E (s) TTOT (s) Frequency
(bursts/min)
VAGAL-INTACT
B6/129 0.19± 0.01 0.33± 0.09 0.52± 0.09 123± 11
Gaa−/ − 0.18± 0.01 0.34± 0.08 0.52± 0.09 126± 8
VAGOTOMIZED
B6/129 0.20± 0.01 0.59± 0.08* 0.79± 0.08 89± 10*
Gaa−/ − 0.20± 0.01 0.57± 0.07* 0.78± 0.07 86± 8**
TI, inspiratory duration; TE, expiratory duration; TTOT, TI +TE. *p< 0.05; **p< 0.01
compared with the value during vagal-intact condition.
observation. Indeed, vagotomy triggered a robust increase in XII
burst amplitude (239± 44% baseline) in B6/129 mice but did not
consistently alter burst amplitude in Gaa−/− mice (130± 23%
baseline; p = 0.02 vs. B6/129). The coefﬁcient of variation of XII
burst amplitude was not different between Gaa−/− and B6/129
mice, and vagotomy reduced amplitude variability in both groups
(p< 0.05; Table 2).
Phrenic burst amplitude (a.u.) was similar between B6/129
(0.40± 0.10) and Gaa−/− mice (0.45± 0.10) during the vagal-
intact condition (Figure 7).However, vagotomy robustly increased
phrenic burst amplitude in B6/129 (190± 32% baseline) but not
Gaa−/− mice (113± 18% baseline; Figure 7). Thus, the normal-
ized phrenic output (% baseline) was blunted in Gaa−/− mice
(p = 0.03 vs. B6/129). The overall range of these values was also
greater in B6/129 (from96 to 339%baseline) compared to Gaa−/−
mice (from 33 to 239% baseline). Following vagotomy, non-
normalized (a.u.) Gaa−/− phrenic burst amplitude (0.43± 0.09)
was approximately 60% of that of B6/129 mice (0.71 ± 0.08) but
this did not reach statistical signiﬁcance (p> 0.05). However, we
noted that an outlier point skewed this result. Speciﬁcally, one
Gaa−/− mouse demonstrated particularly robust phrenic burst-
ing, and this data point met the criteria established by Dixon’s
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FIGURE 4 | Examples of respiratory cycle variability in representative
B6/129 and Gaa−/− mice.The left panel shows a sequential plot of the
total duration of the respiratory cycle (T TOT) for 60 consecutive cycles.
An increase in the breath-to-breath variability inT TOT can be seen in the
Gaa−/ − mouse under both vagal-intact and vagotomized conditions.
The middle and right panels show histograms depicting the overall
distribution of values forT TOT during the 60 respiratory cycles depicted
in the left panel.
outlier test at the 95% conﬁdence level (Verma and Quiroz-Ruiz,
2006). Removal of this point resulted in a statistically signiﬁcant
difference in raw phrenic bursting between Gaa−/− and B6/129
mice (p = 0.01). Nevertheless, this data point is included in the
overall analyses because this may reﬂect the “clinical spectrum” of
Pompe disease. Indeed the range of values observed for both raw
and normalized neural output in this study may reﬂect variance in
the relative rate of disease progression and associated neuropathol-
ogy (Sidman et al., 2008; DeRuisseau et al., 2009). In this regard,
it is interesting that a recent systematic review of a large sample of
Pompe patients with symptom onset after 12month of age found
a wide range of pulmonary function. For example, forced vital
capacity (FVC) ranged from as low as 3%, to as much as 123% of
normal (Byrne et al., 2011a).
A few additional anecdotal observations are pertinent. First, we
noted that those Gaa−/− mice with the most striking locomo-
tor deﬁcits tended to have the weakest phrenic output. Second,
those Gaa−/− mice with more robust phrenic output tended to
have blunted XII activity (e.g., Figure 6). Thus, the amplitude
(a.u.) of the phrenic signal in Gaa−/− mice did not correlate with
the XII burst amplitude (r2 = 0.048; p = 0.384). In contrast, the
same two variables were signiﬁcantly correlated in B6/129 mice
(r2 = 0.272; p = 0.038). This observation could reﬂect a differen-
tial onset of neuropathology and associated symptoms between
the XII and phrenic motor pools. This is potentially important
since overt symptoms of altered tongue motor control can present
before ventilatory failure in Pompe infants (Byrne, unpublished
observations).
DISCUSSION
This study provides the ﬁrst evidence that medullary glycogen
accumulation is associated with alterations in the neural control
of XII motoneurons. PAS staining of brainstem tissues conﬁrmed
widespread neuropathology in Pompe mice (Sidman et al., 2008;
DeRuisseau et al., 2009) anddocumented extensive somal glycogen
accumulation in XII motoneurons. Neurophysiology experiments
revealed altered XII nerve output and increased respiratory cycle
variability in Gaa−/− mice. Thus, systemic GAA deﬁciency is
associated with instability in the respiratory control circuits, and
apparently reduced neural drive to the tongue. Altered control
of the tongue and other pharyngeal muscles could contribute
to upper airway instability as well as speech and/or swallow
dysfunction in Pompe disease (Jones et al., 2010).
RESPIRATORY ACTIVITY IN POMPE MICE
Prior work has shown that Gaa−/− mice have respiratory-related
functional impairments including reduced diaphragm muscle
contractility and attenuated minute ventilation (Mah et al., 2007,
2010; DeRuisseau et al., 2009). The present observation of altered
respiratory timing in Gaa−/− mice is consistent with the hypoth-
esis that systemic GAA deﬁciency can alter the neural control of
breathing (DeRuisseau et al., 2009). The mechanisms underly-
ing the increased variability in the respiratory cycle are not clear,
but previous studies may provide insight. For example, CNS deﬁ-
ciencies in brain-derived neurotrophic factor (Balkowiec andKatz,
1998), norepinephrine (Viemari et al., 2005) and serotonin (Erick-
son et al., 2007) are also associated with increased variability in
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FIGURE 5 |The coefficient of variation (CV) of inspiratory [T I , (A)],
expiratory [T E, (B)], and total respiratory cycle [TTOT, (C)] duration
during vagal-intact and vagotomized conditions. CV ofT I andT TOT is
signiﬁcantly higher in vagotomized Gaa−/ − mice than B6/129 mice.
*p< 0.05; **p< 0.01 signiﬁcant different from B6/129 mice. #p< 0.05
compared with the value during vagal-intact condition.
the respiratory cycle. Thus, respiratory pattern irregularities can
be triggered by various CNS pathologies, and we suggest that the
present results may arise due to altered function in the neuronal
circuitry controlling respiratory output in Gaa−/− mice.
The widespread neuropathology observed in Pompe animal
models (current data; see also Mancall et al., 1965; Gambetti
et al., 1971; Sidman et al., 2008) makes it hard to pinpoint a
precise anatomical location to explain the enhanced variability
in respiratory output. In preliminary experiments (unpublished
observations) using the transynaptic tracer pseudo-rabies virus
FIGURE 6 | Examples of Pre-I XII bursting in B6/129 and Gaa−/− mice.
These examples were taken from vagotomized, ventilated mice.We noted
anecdotally that Pre-I XII bursting (i.e., bursting before the onset of the
phrenic burst) was evident in B6/129 but not Gaa−/ − mice. In the examples,
the solid vertical line indicates the onset of inspiratory phrenic bursting and
the vertical dashed line represents the onset of Pre-I XII activity. The
horizontal line indicates the end-expiratory amplitude prior to inspiration.
This particular Gaa−/ − mouse example was chosen to illustrate that in cases
where Gaa−/ − mice showed more robust phrenic bursting, the same animal
tended to show reduced efferent XII output (see text for further
description).
(PRV; see Lane et al., 2008), we noted that glycogen accumu-
lates in Gaa−/− mice in the presumed location of the ventral
respiratory group – a location that includes respiratory premo-
tor neurons (Feldman et al., 2003). Facial motoneurons in Pompe
mice also have enlarged lysosomes with positive PAS staining (Sid-
man et al., 2008). This is noteworthy since the facial nerve can
show inspiratory bursting (Lee and Fuller, 2010b), and the facial
motor nucleus is in close proximity to components of the respi-
ratory rhythm circuitry (i.e., the parafacial respiratory group or
pFRG). The pFRG may be essential to the production of the over-
all respiratory rhythm, or may function more exclusively as an
expiratory rhythm generator (Feldman and Del Negro, 2006; Oni-
maru et al., 2006). Finally, the nucleus of the solitary tract (NTS)
is a primary integrative site for peripheral afferents regulating car-
diorespiratory function (Boscan et al., 2002; Kubin et al., 2006),
and dysfunction within this neuronal population could contribute
to the impaired vagal reﬂexes noted in this study (e.g., Figures 3
and 4). NTS dysfunction could also contribute to increased res-
piratory variability since impairment of chemoafferent input can
destabilize respiration (Hofer, 1984). In the current studywenoted
glycogen accumulation in the putative region of theNTS, although
the speciﬁc location was not conﬁrmed with labeling techniques.
In addition to pattern abnormalities, analyses of XII bursting
in Gaa−/− mice suggested alterations in efferent bursting. Speciﬁ-
cally, we noted less robust bursting during baseline conditions and
a blunted response to bilateral vagotomy (Figure 3). Vagotomy
typically triggers substantial increases in efferent XIImotor output
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FIGURE 7 | Inspiratory phrenic and XII burst amplitude B6/129 and
Gaa−/− mice.The amplitude of phrenic (A) and XII (B) neurogram
inspiratory burst amplitudes were expressed as arbitrary units (a.u.), and
normalized to the activity recorded under vagal-intact conditions (C).
Cervical vagotomy caused robust increases in XII burst amplitude in B6/129
but not Gaa−/ − mice. See text for a commentary on the phrenic burst
amplitude. *p< 0.05; **p< 0.01 signiﬁcant different from B6/129 mice.
#p< 0.05; ##p< 0.01 compared with the value during vagal-intact condition.
(Fuller et al., 1999; Lee et al., 2007a), and accordingly our results
suggest that either vagally mediated reﬂexes are impaired in
Gaa−/− mice, or that there is a non-speciﬁc impairment in the
ability to increase the baseline (i.e.,“quiet breathing”) efferent res-
piratory output (DeRuisseau et al., 2009). The mechanisms asso-
ciated with potentially blunted efferent output could be distinct
Table 2 | The coefficient of variation of phrenic and XII nerve
amplitude in B6/129 and Gaa−/− mice.
Phrenic (%) XII (%)
VAGAL-INTACT
B6/129 7.1± 0.8 7.9± 0.8
Gaa−/ − 7.0± 0.8 9.2± 0.7
VAGOTOMIZED
B6/129 4.6± 0.7* 5.4± 0.9*
Gaa−/ − 6.4± 0.6 6.8± 0.9*
*p< 0.05 compared with the value during vagal-intact condition.
from those associated with the altered respiratory timing. For
example, glycogen accumulation in XII motoneuron cell bodies
could directly lead to impaired motor output (DeRuisseau et al.,
2009).
Another interesting observation was that Pre-I XII motor out-
put was altered in Gaa−/− mice. The Pre-I XII burst may act
to stabilize the pharyngeal airway prior to the onset of negative
intraluminal pressure during inspiration (Lee et al., 2007b). Thus,
the absence of Pre-I XII activity during elevated respiratory drive
(e.g.,post-vagotomy) could lead to an increase in airﬂow resistance
during inspiration.Most work on themechanisms of upper airway
patency during breathing focused on the genioglossus which is an
extrinsic tongue muscle that acts to protrude the tongue (Rem-
mers et al., 1978; Fregosi and Fuller, 1997). However, the intrinsic
muscles which comprise the body of the tongue, as well as the
extrinsic muscles which serve to retract the tongue are also impor-
tant to airway patency (Fuller et al., 1998, 1999; Bailey and Fregosi,
2004; Bailey et al., 2006). For example, the tongue retrusor mus-
cles can reduce airway compliance (i.e., “stiffen” the airway; Fuller
et al., 1999), and activation of the intrinsic tongue musculature
facilitates airway dilation (Bailey et al., 2006). The motoneurons
controlling the extrinsic tongue muscles are compartmentalized
within the XII nucleus, whereas the intrinsic muscle motoneurons
are distributed throughout the nucleus (Uemura-Sumi et al., 1988;
Guo et al., 1996;McClung andGoldberg,1999). In our study glyco-
gen accumulation occurred in neuronal soma throughout the XII
nucleus (Figures 1 and 2) suggesting that motoneurons projecting
to both intrinsic and extrinsic tongue muscles were affected.
We noted similarities but also a discrepancy between the cur-
rent data set and our prior report in Gaa−/− mice (DeRuisseau
et al., 2009). However, the fundamental conclusions between the
prior and current data sets are similar. Namely, both studies indi-
cate that GAA deﬁciency is associated with pathology in and
around respiratory motoneurons (see also Sidman et al., 2008).
Indeed the neuronal medullary glycogen accumulation reported
here (e.g., Figures 1 and 2) is similar to spinal cord histological
and biochemical results from our prior report (DeRuisseau et al.,
2009). Similarly, in our prior report we observed reduced phrenic
efferent activity in vagotomized Gaa−/− vs. control (B6/129)
mice. Here we found that normalized phrenic and XII bursting
was less in Gaa−/− mice, and the raw phrenic burst amplitude
was qualitatively consistent with our prior report (i.e., lower in
Gaa−/− mice). However, we previously noted substantial reduc-
tions in burst frequency in Gaa−/− mice (DeRuisseau et al., 2009)
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whereas in the present study respiratory burst frequency was sim-
ilar between groups. This discrepancy could reﬂect the overall
health of the Gaa−/− mice, subtle differences in the experimental
procedures, or possibly genetic factors. The Gaa−/− mice in our
study were genotyped, but the current study was conducted sev-
eral years after our initial report, and we cannot rule out possible
differences within the Gaa−/− colony. For example, even within
a particular rodent strain (e.g., Sprague-Dawley rats), differences
in respiratory control mechanisms are present depending on the
particular colony of animals (Fuller et al., 2001; Wilkerson and
Mitchell, 2009; Baker-Herman et al., 2010).
SIGNIFICANCE
Respiratory insufﬁciency in Pompe disease has historically been
attributed to muscular failure (Pellegrini et al., 2005; Burghaus
et al., 2006). While respiratory muscle pathology almost certainly
makes a contribution to respiratory failure, the current data con-
tribute to a growing consensus that motor failures in Pompe
disease may also involve CNS pathology (Hogan et al., 1969; Mar-
tin et al., 1973; Matsui et al., 1983; Teng et al., 2004; Sidman et al.,
2008; DeRuisseau et al., 2009; Burrow et al., 2010; Mah et al.,
2010). Pompe respiratory deﬁcits, in particular, may have both a
spinal (DeRuisseau et al., 2009) and supraspinal component (cur-
rent data). Consistent with the current mouse data, a few Pompe
case reports have documented brainstem glycogen accumulation
(Mancall et al., 1965; Teng et al., 2004). In addition, there are
clinical reports of impaired upper airway function. For example,
swallowdysfunction occurs in infantile Pompe disease (Jones et al.,
2010), and speech problems are common, even after initiation of
enzyme replacement therapy (Muller et al., 2009). Feeding difﬁcul-
ties are present in>70%of Pompe infants, and approximately 50%
of patients are never fed by mouth (Byrne et al., 2011a). In addi-
tion, obstructive sleep apnea, which may reﬂect inadequate neural
drive to the pharyngeal muscles during sleep (Horner, 2008), is
prevalent in adult Pompe patients (Margolis et al., 1994). Each
of these upper airway-related clinical problems could reﬂect, at
least in part, impaired XII motoneuron function. Accordingly, the
XII motoneuron pathology and altered output in Gaa−/− mice
suggests that aspects of tongue dysfunction in Pompe patients
may have a neural basis.
The current “best-practice” therapy for Pompe disease involves
repeated intravenous infusion of recombinantly produced GAA
enzyme (Beck, 2009; Byrne et al., 2011a). However, the recom-
binant GAA enzyme does not effectively cross the blood–brain-
barrier where the protein may inﬂuence CNS GAA deﬁciency
(Kikuchi et al., 1998; Raben et al., 2003). Accordingly, while
intravenous GAA delivery can target cardiac and skeletal mus-
cle (Levine et al., 2008; Sugai et al., 2010), it will not effectively
mitigate CNS glycogen accumulation (Byrne et al., 2011b). This
point is highlighted by our recent case study report in which a
Pompe infant which had received enzyme replacement therapy
showed considerable glycogen accumulation in the spinal cord on
post-mortem examination (DeRuisseau et al., 2009). It should be
emphasized however, that enzyme replacement therapy will pro-
long life in Pompe infants (Kishnani et al., 2009; Nicolino et al.,
2009; Byrne et al., 2011a). Nevertheless, variability in the suc-
cess of enzyme replacement (van den Hout et al., 2004) could
reﬂect persistent CNS pathology. For example,Muller et al. (2009)
reported that even with enzyme replacement therapy, children
with Pompe disease are still at high risk for developing speech
disorders. These authors speculated that this could reﬂect lower
motoneuron involvement which would not be effectively targeted
by the enzyme therapy. Based on the current data and both recent
(Sidman et al., 2008; DeRuisseau et al., 2009; Muller et al., 2009)
and historical reports (Mancall et al., 1965; Hogan et al., 1969;
Gambetti et al., 1971), we hypothesize that therapies targeting
both skeletal muscle and the CNS may be required to fully correct
respiratory-related deﬁcits, and in particular pharyngeal muscle
control, in Pompe disease (Byrne et al., 2011b).
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